Poor immediate tolerability of amphotericin B lipid emulsion in patients with haematological malignancies. Haematology-Microbiology Group.
Laverdière
M
M
Habel
F
F
Weiss
K
K
Delorme
J
J
Dubois
G
G
Gagnon
N
N
Bélanger
R
R
D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D005334:Fever / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D005217:Fat Emulsions, Intravenous; D000666:Amphotericin B